This article is more than 5 years old. Information may no longer be current.

VIDEO: Researchers look at effect of L-DOPA on timing of AMD onset

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Andrew A. Moshfeghi, MD, shares new research published in American Journal of Medicine, in which a later than expected onset of age-related macular degeneration was seen in patients taking exogenous L-DOPA for other medical conditions.